tiprankstipranks
Advertisement
Advertisement

Tenon Medical Receives Nasdaq Minimum Bid Price Deficiency Notice

Story Highlights
  • Tenon Medical was notified on February 25, 2026, that it failed Nasdaq’s $1 minimum bid requirement over a 30-day period. The company has until August 24, 2026, to regain compliance and could receive another 180 days if it meets other listing standards.
  • If Tenon does not regain compliance, its stock may be delisted from Nasdaq, though it could appeal the decision to a hearings panel. The shares remain listed under “TNON” as the company evaluates options, including a potential reverse stock split, raising listing-risk concerns for investors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Tenon Medical Receives Nasdaq Minimum Bid Price Deficiency Notice

Meet Samuel – Your Personal Investing Prophet

Tenon Medical, Inc. ( (TNON) ) has shared an update.

On February 25, 2026, Tenon Medical disclosed it had received a Nasdaq notification that its common stock failed to meet the $1.00 minimum closing bid price requirement for 30 consecutive business days from January 9 to February 24, 2026. The company has until August 24, 2026, to regain compliance by achieving at least $1.00 per share for 10 consecutive business days, with the possibility of an additional 180-day grace period if certain other listing standards are met.

If Tenon Medical does not restore compliance within the allotted periods, its shares could be delisted from Nasdaq, though the company would have the right to appeal any delisting decision to a hearings panel. Tenon’s stock remains listed and trading under the symbol “TNON” while the company evaluates options, including a potential reverse stock split, underscoring heightened listing risk for shareholders and regulatory pressure on the company’s market standing.

The most recent analyst rating on (TNON) stock is a Hold with a $0.75 price target. To see the full list of analyst forecasts on Tenon Medical, Inc. stock, see the TNON Stock Forecast page.

Spark’s Take on TNON Stock

According to Spark, TipRanks’ AI Analyst, TNON is a Neutral.

The score is held back most by persistent large losses and ongoing cash burn, despite improving revenue and gross margins and a healthier, low-debt balance sheet. Technicals remain bearish with the stock below major moving averages. The latest earnings call and financing activity are constructive for growth and liquidity, but profitability and self-funding are not yet in sight.

To see Spark’s full report on TNON stock, click here.

More about Tenon Medical, Inc.

Tenon Medical, Inc. is a publicly traded company listed on The Nasdaq Capital Market under the ticker symbol “TNON.” The company’s common stock is subject to Nasdaq’s continued listing requirements, including maintaining a minimum bid price threshold, which is a key condition for remaining on the exchange.

Average Trading Volume: 1,009,935

Technical Sentiment Signal: Sell

Current Market Cap: $9.36M

Learn more about TNON stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1